rs144458353

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_003183.6(ADAM17):​c.53C>T​(p.Pro18Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000386 in 1,603,296 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 1 hom. )

Consequence

ADAM17
NM_003183.6 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.695

Publications

4 publications found
Variant links:
Genes affected
ADAM17 (HGNC:195): (ADAM metallopeptidase domain 17) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn's disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]
ADAM17 Gene-Disease associations (from GenCC):
  • inflammatory skin and bowel disease, neonatal, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • neonatal inflammatory skin and bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.058347523).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000197 (30/152274) while in subpopulation NFE AF = 0.000382 (26/68022). AF 95% confidence interval is 0.000267. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003183.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAM17
NM_003183.6
MANE Select
c.53C>Tp.Pro18Leu
missense
Exon 1 of 19NP_003174.3
ADAM17
NM_001382777.1
c.-628C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 19NP_001369706.1
ADAM17
NM_001382778.1
c.-870C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 19NP_001369707.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAM17
ENST00000310823.8
TSL:1 MANE Select
c.53C>Tp.Pro18Leu
missense
Exon 1 of 19ENSP00000309968.3
ADAM17
ENST00000478059.1
TSL:1
n.222C>T
non_coding_transcript_exon
Exon 1 of 5
ADAM17
ENST00000618923.2
TSL:1
n.53C>T
non_coding_transcript_exon
Exon 1 of 8ENSP00000480552.1

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152156
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000170
AC:
39
AN:
228990
AF XY:
0.000137
show subpopulations
Gnomad AFR exome
AF:
0.000211
Gnomad AMR exome
AF:
0.0000927
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000302
Gnomad OTH exome
AF:
0.000357
GnomAD4 exome
AF:
0.000406
AC:
589
AN:
1451022
Hom.:
1
Cov.:
31
AF XY:
0.000359
AC XY:
259
AN XY:
720892
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33332
American (AMR)
AF:
0.0000925
AC:
4
AN:
43264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25874
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39222
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84324
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5738
European-Non Finnish (NFE)
AF:
0.000501
AC:
555
AN:
1106884
Other (OTH)
AF:
0.000434
AC:
26
AN:
59866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152274
Hom.:
0
Cov.:
32
AF XY:
0.000201
AC XY:
15
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41544
American (AMR)
AF:
0.0000654
AC:
1
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000372
Hom.:
1
Bravo
AF:
0.000261
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000466
AC:
4
ExAC
AF:
0.000157
AC:
19

ClinVar

ClinVar submissions as Germline

Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inflammatory skin and bowel disease, neonatal, 1 (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.085
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.81
L
PhyloP100
0.69
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.37
N
REVEL
Benign
0.047
Sift
Benign
0.095
T
Sift4G
Benign
0.47
T
Polyphen
0.61
P
Vest4
0.16
MVP
0.62
MPC
0.39
ClinPred
0.051
T
GERP RS
0.39
PromoterAI
-0.0044
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.037
gMVP
0.51
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144458353; hg19: chr2-9695682; API